Trials / Conditions / Solid Tumors and Hematologic Malignancy
Solid Tumors and Hematologic Malignancy
6 registered clinical trials studyying Solid Tumors and Hematologic Malignancy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancie NCT02712905 | Incyte Corporation | Phase 1 / Phase 2 |
| Completed | A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients NCT02492789 | Atridia Pty Ltd. | Phase 1 |
| Terminated | An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies NCT02431260 | Incyte Corporation | Phase 1 / Phase 2 |
| Withdrawn | Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor R NCT02355431 | Incyte Corporation | Phase 2 |
| Completed | A Dose-escalation Study in Subjects With Advanced Malignancies NCT01195311 | Incyte Corporation | Phase 1 |
| Completed | Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors NCT00820560 | Incyte Corporation | Phase 1 |